$92.88
-3.4%Church & Dwight Co., Inc. develops, manufactures, and markets household, personal care, and specialty products. It operates through three segments: Consumer Domestic, Consumer International, and Specialty Products Division. The company offers cat litters, carpet deodorizers, laundry detergents, and baking soda, as well as other baking soda based products under the ARM & HAMMER brand; condoms, lubricants, and vibrators under the TROJAN brand; stain removers, cleaning solutions, laundry detergents, and bleach alternatives under the OXICLEAN brand; battery-operated and manual toothbrushes under the SPINBRUSH brand; home pregnancy and ovulation test kits under the FIRST RESPONSE brand; depilatories under the NAIR brand; oral analgesics under the ORAJEL brand; laundry detergents under the XTRA brand; gummy dietary supplements under the L'IL CRITTERS and VITAFUSION brands; dry shampoos under the BATISTE brand; water flossers and replacement showerheads under the WATERPIK brand; FLAWLESS products; cold shortening and relief products under the ZICAM brand; and oral care products under the THERABREATH brand. Its specialty products include animal productivity products, such as MEGALAC rumen bypass fat, a supplement that enables cows to maintain energy levels during the period of high milk production; BIO-CHLOR and FERMENTEN, which are used to reduce health issues associated with calving, as well as provides needed protein; and CELMANAX refined functional carbohydrate, a yeast-based prebiotic. The company offers sodium bicarbonate; and cleaning and deodorizing products. It sells its consumer products through supermarkets, mass merchandisers, wholesale clubs, drugstores, convenience stores, home stores, dollar and other discount stores, pet and other specialty stores, and websites and other e-commerce channels; and specialty products to industrial customers and livestock producers through distributors. The company was founded in 1846 and is headquartered in Ewing, New Jersey.
Chief Financial Officer & Executive Vice President
EVice President & Chief Supply Chain Officer
Compensation
$534,425
EVice President & Chief Supply Chain Officer
Compensation
$534,425
Executive Vice President & Chief Human Resources Officer
Executive Vice President & Chief Information Officer
Executive Vice President of International
Compensation
$1,016,983
Executive Vice President of Strategy, M&A and Business Partnerships
Executive Vice President, Chief Technology Officer & Global New Product Innovation
Compensation
$1,321,907
Executive Vice President, General Counsel & Secretary
Compensation
$1,109,282
Executive Vice President. President Consumer International & Specialty Products Division
Compensation
$1,016,983
President, Chief Executive Officer & Director
Compensation
$1,892,266
Senior Vice President & Chief Marketing Officer
During the last 12 months, insiders have purchased $1.18M and sold $3.21M worth of CHD shares, resulting in $2.03M of net selling activity.
0
0.00
13.0K
1.27M
-1.3M
-$1.27M
0
0.00
13.0K
1.31M
-1.3M
-$1.31M
0
0.00
0
0.00
+0
+$0
12.9K
1.18M
6.4K
627.16K
+551K
+$551K
Dierker Richard A
Director, Officer: President And Ceo
$501K
Mcchesney Lee B
Officer: Evp, Chief Financial Officer
$494K
Read Michael
Officer: Evp, International
$183K
Vergis Janet S.
Director
$1.31M
Price Penry W
Director
$1.27M
Hooker Carlen
Officer: Evp, Chief Commercial Officer
$627K
Negative insider sentiment with $2.03M net selling. Selling notably exceeds buying, warranting closer scrutiny of company fundamentals.
Weak buy/sell ratio. Selling significantly exceeds buying—monitor for potential fundamental concerns.
Heavy recent selling activity. Recent insider sales notably exceed purchases—may warrant investigation into company developments.
3 insider buyers and 3 sellers. Equal participation suggests mixed or neutral insider views.
Multiple red flags: Heavy selling, numerous sellers, and continued recent selling create a concerning pattern. Investigate fundamental drivers and consider whether company guidance or industry conditions have deteriorated.
CHD - Filing history and reports
| Filing Type | Filing Date | Period Ending | Fiscal Year | Actions |
|---|---|---|---|---|
DEF 14A DEF 14A 2026 N/A | March 19, 2026 | May 01, 2026 | 2026 | |
DEF 14A DEF 14A 2025 N/A | March 20, 2025 | May 01, 2025 | 2025 | |
DEF 14A DEF 14A 2024 N/A | March 22, 2024 | May 02, 2024 | 2024 | |
DEF 14A DEF 14A N/A | March 17, 2023 | March 17, 2023 | ||
DEF 14A DEF 14A 2022 N/A | March 18, 2022 | April 28, 2022 | 2022 | |
DEF 14A DEF 14A 2021 N/A | March 19, 2021 | April 29, 2021 | 2021 | |
DEF 14A DEF 14A 2020 N/A | March 20, 2020 | April 30, 2020 | 2020 | |
DEF 14A DEF 14A 2019 N/A | March 22, 2019 | May 02, 2019 | 2019 | |
DEF 14A DEF 14A 2018 N/A | March 23, 2018 | May 03, 2018 | 2018 | |
DEF 14A DEF 14A 2017 N/A | March 22, 2017 | May 04, 2017 | 2017 |
Snapshot
Start with context, operating signals, and key market metrics.
Value Model
Stress test fair value across bear, base, and bull assumptions.
Statements
Validate revenue quality, margins, and balance sheet durability.
Earnings Call
Read management commentary and compare it with reported outcomes.
Dividends
Check payout sustainability and long-term distribution behavior.
Analyst Expectations
Review consensus spread and where estimate risk is concentrated.